Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study.
Sato S, Ssuzuki T, Chinen T, Yamaguchi H, Suzuki Y, Hokamura N, Saze Z, Kono K, Takahashi K, Yano F, Kunisaki C, Kosaka T, Endo I, Ichikawa Y, Miyawaki Y, Sato H, Shimada H. Sato S, et al. Among authors: shimada h. Int J Clin Oncol. 2024 Apr 28. doi: 10.1007/s10147-024-02532-0. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38679627
The new prognostic score for unresectable or recurrent gastric cancer treated with nivolumab: A multi-institutional cohort study.
Sato S, Oshima Y, Matsumoto Y, Seto Y, Yamashita H, Hayano K, Kano M, Ono HA, Mitsumori N, Fujisaki M, Kunisaki C, Akiyama H, Endo I, Ichikawa Y, Urakami H, Kubo H, Nagaoka S, Shimada H. Sato S, et al. Among authors: shimada h. Ann Gastroenterol Surg. 2021 Jul 13;5(6):794-803. doi: 10.1002/ags3.12489. eCollection 2021 Nov. Ann Gastroenterol Surg. 2021. PMID: 34755011 Free PMC article.
Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal Society.
Suzuki T, Yajima S, Okamura A, Yoshida N, Taniyama Y, Murakami K, Ohkura Y, Nakajima Y, Yagi K, Fukuda T, Ogawa R, Hoshino I, Kunisaki C, Narumiya K, Tsubosa Y, Yamada K, Shimada H; Japan Esophageal Society Promotion Research: p53 Antibody Multicenter Research Group. Suzuki T, et al. Among authors: shimada h. Dis Esophagus. 2022 Dec 14;35(12):doac029. doi: 10.1093/dote/doac029. Dis Esophagus. 2022. PMID: 35661884
A survey of the clinical outcomes of cervical esophageal carcinoma surgery focusing on the presence or absence of laryngectomy using the National Clinical Database in Japan.
Nakajima Y, Tachimori H, Miyawaki Y, Fujiwara N, Kawada K, Sato H, Miyata H, Sakuramoto S, Shimada H, Watanabe M, Kakeji Y, Doki Y, Kitagawa Y. Nakajima Y, et al. Among authors: shimada h. Esophagus. 2022 Oct;19(4):569-575. doi: 10.1007/s10388-022-00944-3. Epub 2022 Jul 28. Esophagus. 2022. PMID: 35902490
Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research.
Ishioka N, Suzuki T, Yajima S, Murakami K, Ohkura Y, Fukuda T, Yagi K, Okamura A, Hoshino I, Kunisaki C, Nakajima Y, Narumiya K, Ogawa R, Shimada H. Ishioka N, et al. Among authors: shimada h. Ann Thorac Cardiovasc Surg. 2022 Jun 20;28(3):163-170. doi: 10.5761/atcs.oa.21-00195. Epub 2022 Jun 17. Ann Thorac Cardiovasc Surg. 2022. PMID: 34690219 Free PMC article.
Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal Society.
Suzuki T, Yajima S, Okamura A, Yoshida N, Taniyama Y, Murakami K, Ohkura Y, Nakajima Y, Yagi K, Fukuda T, Ogawa R, Hoshino I, Kunisaki C, Narumiya K, Tsubosa Y, Yamada K, Shimada H. Suzuki T, et al. Among authors: shimada h. Ann Thorac Cardiovasc Surg. 2024;30(1):24-00028. doi: 10.5761/atcs.oa.24-00028. Ann Thorac Cardiovasc Surg. 2024. PMID: 38583987 Free PMC article.
3,282 results